APA (7th ed.) Citation

Helliwell, J. A., Malone, A., Kowalski, M. M., Dobek, C., Peck, V., & Loss, T. (2024). 418 - PHARMACOKINETICS OF EP-104IAR LONG-ACTING FLUTICASONE PROPIONATE FOR INTRA ARTICULAR INJECTION IN 163 SUBJECTS FROM SPRINGBOARD, A PHASE 2 STUDY IN KNEE OSTEOARTHRITIS. Osteoarthritis and cartilage, 32, S296. https://doi.org/10.1016/j.joca.2024.02.431

Chicago Style (17th ed.) Citation

Helliwell, James A., Amanda Malone, Mark M. Kowalski, Christine Dobek, Vik Peck, and Troy Loss. "418 - PHARMACOKINETICS OF EP-104IAR LONG-ACTING FLUTICASONE PROPIONATE FOR INTRA ARTICULAR INJECTION IN 163 SUBJECTS FROM SPRINGBOARD, A PHASE 2 STUDY IN KNEE OSTEOARTHRITIS." Osteoarthritis and Cartilage 32 (2024): S296. https://doi.org/10.1016/j.joca.2024.02.431.

MLA (9th ed.) Citation

Helliwell, James A., et al. "418 - PHARMACOKINETICS OF EP-104IAR LONG-ACTING FLUTICASONE PROPIONATE FOR INTRA ARTICULAR INJECTION IN 163 SUBJECTS FROM SPRINGBOARD, A PHASE 2 STUDY IN KNEE OSTEOARTHRITIS." Osteoarthritis and Cartilage, vol. 32, 2024, p. S296, https://doi.org/10.1016/j.joca.2024.02.431.